Table 6. Studies examining prognostic impact of immune cells in bladder cancer.
Study | Number patients | Result | Association | Cell type |
---|---|---|---|---|
(Krpina et al, 2015) | 115 | CD3+ and CD8+ TIL are predictive of bladder cancer recurrence in patients with solitary low-grade non-muscle invasive bladder cancer | Positive association | CD3 and CD8 |
(Wang et al, 2015) | 302 | Intratumoural CD103(+) TILs inversely associated with tumour size. High CD103+ cells associated with improved OS. | Positive association | CD103+ |
(Zhang et al, 2015) | 131 | Tumour-infiltrating CD4(+) T cell density emerged as an independent prognostic factor for OS (HR: 2.75; P=0.004) | Positive association | CD4 |
Knief et al (2016) | 149 | FOXP3/CD8 (OS: P=0.013, HR: 1.32, 95% CIs: 1.06–1.65) ratios were significantly associated with briefer OS and time to cancer-specific death | Negative association | FOXP3/CD8 ratio |
(Sjodahl et al, 2014) | 296 | CD3(+) TILs was significantly associated with good prognosis. Positive association with CD3 was modulated by CD68(+) TAMs. Strongest negative association with survival was a high ratio between CD68 and CD3 | Positive association; Negative association | CD3+ High CD68/CD3 ratio |
(Sharma et al, 2007) | 69 | Higher numbers of CD8 TILs within the tumour (> or =8) had better DFS and OS | Positive association | CD8 |
(Hilmy et al, 2006) | 103 | No correlation between TIL level and prognosis | No association | TILs |
Abbreviations: TAM=tumour-associated macrophage; OS=overall survival; TIL=tumour-infiltrating lymphocytes.